Rheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotonin (N-f-5HT), with methotrexate (MTX), the standard in RA therapy, in the chronic phase of adjuvant-induced arthritis (AA) in male Lewis rats. The experiment included healthy controls (CO), arthritic animals (AA), AA given N-f-5HT (AA-N-f-5HT), and AA given MTX (AA-MTX). N-f-5HT did not affect the body weight change and clinical parameters until the 14th experimental day. Its positive effect was rising during the 28-day experiment, indicating a delayed onset of N-f-5HT action. Administration of either N-f-5HT or MTX caused reduction of inflammation measured as the level of CRP in plasma and the activity of LOX in the liver. mRNA transcription of TNF-α and iNOS in the liver was significantly attenuated in both MTX and N-f-5HT treated groups of arthritic rats. Interestingly, in contrast to MTX, N-f-5HT significantly lowered the level of IL-1β in plasma and IL-1β mRNA expression in the liver and spleen of arthritic rats. This speaks for future investigations of N-f-5HT as an agent in the treatment of RA in combination therapy with MTX.

Department of Cell and Molecular Biology of Drugs Faculty of Pharmacy Comenius University 832 32 Bratislava Slovakia

Faculty of Food and Biochemical Technology University of Chemistry and Technology 166 28 Prague Czech Republic

Institute of Experimental Pharmacology and Toxicology Slovak Academy of Sciences 841 04 Bratislava Slovakia

Institute of Experimental Pharmacology and Toxicology Slovak Academy of Sciences 841 04 Bratislava Slovakia; Department of Galenic Pharmacy Faculty of Pharmacy Comenius University 832 32 Bratislava Slovakia

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic 166 10 Prague Czech Republic

See more in PubMed

Sangha O. Epidemiology of rheumatic diseases. Rheumatology. 2000;39(2):3–12. PubMed

Seven A., Güzel S., Aslan M., Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clinical Biochemistry. 2008;41(7-8):538–543. doi: 10.1016/j.clinbiochem.2008.01.029. PubMed DOI

Choy E. H. S., Panayi G. S. Cytokine pathways and joint inflamation in rheumatoid arthritis. The New England Journal of Medicine. 2001;344(12):907–916. doi: 10.1056/nejm200103223441207. PubMed DOI

Yonekura Y., Koshiishi I., Yamada K.-I., et al. Association between the expression of inducible nitric oxide synthase by chondrocytes and its nitric oxide-generating activity in adjuvant arthritis in rats. Nitric Oxide—Biology and Chemistry. 2003;8(3):164–169. doi: 10.1016/s1089-8603(03)00025-9. PubMed DOI

Comar J. F., Babeto De Sá-Nakanishi A., De Oliveira A. L., et al. Oxidative state of the liver of rats with adjuvant-induced arthritis. Free Radical Biology and Medicine. 2013;58:144–153. doi: 10.1016/j.freeradbiomed.2012.12.003. PubMed DOI

Taylor B. S., Alarcon L. H., Billiar T. R. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry. 1998;63(7):766–781. PubMed

Smolen J. S., Steiner G. Therapeutic strategies for rheumatoid arthritis. Nature Reviews Drug Discovery. 2003;2(6):473–488. doi: 10.1038/nrd1109. PubMed DOI

Mori T., Miyamoto T., Yoshida H., et al. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. International Immunology. 2011;23(11):701–712. doi: 10.1093/intimm/dxr077. PubMed DOI

Haruna Y., Morita Y., Yada T., Satoh M., Fox D. A., Kashihara N. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis and Rheumatism. 2007;56(6):1827–1835. doi: 10.1002/art.22632. PubMed DOI

Cojocaru M., Cojocaru I. M., Silosi I., Vrabie C. D., Tanasescu R. Extra-articular manifestations in rheumatoid arthritis. Maedica. 2010;5(4):286–291. PubMed PMC

Song Y. L., Foster W. R., Shuster D. J., Nadler S. G., Salter-Cid L., Sasseville V. G. Transcriptional profiling of liver and effect of glucocorticoids in a rat adjuvant-induced arthritis model. Veterinary Pathology. 2011;48(4):885–895. doi: 10.1177/0300985810390018. PubMed DOI

Sundaram M. S., Hemshekhar M., Thushara R. M., et al. Tamarind seed extract mitigates the liver oxidative stress in arthritic rats. Food & Function. 2014;5(3):587–597. doi: 10.1039/c3fo60381d. PubMed DOI

Bendele A., Mccomb J., Gould T., et al. Animal models of arthritis: relevance to human disease. Toxicologic Pathology. 1999;27(1):134–142. doi: 10.1177/019262339902700125. PubMed DOI

Fujikado N., Saijo S., Iwakura Y. Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis. Arthritis Research & Therapy. 2006;8(4):R100–R113. doi: 10.1186/ar1985. PubMed DOI PMC

Pandey K. B., Rizvi S. I. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Medicine and Cellular Longevity. 2009;2(5):270–278. doi: 10.4161/oxim.2.5.9498. PubMed DOI PMC

Relja B., Töttel E., Breig L., et al. Plant polyphenols attenuate hepatic injury after hemorrhage/resuscitation by inhibition of apoptosis, oxidative stress, and inflammation via NF-kappaB in rats. European Journal of Nutrition. 2012;51(3):311–321. doi: 10.1007/s00394-011-0216-1. PubMed DOI

de Almeida Gonçalves G., de Sá-Nakanishi A. B., Wendt M. M. N., et al. Green tea extract improves the oxidative state of the liver and brain in rats with adjuvant-induced arthritis. Food & Function. 2015;6(8):2701–2711. doi: 10.1039/c5fo00548e. PubMed DOI

Ly D., Kang K., Choi J.-Y., Ishihara A., Back K., Lee S.-G. HPLC analysis of serotonin, tryptamine, tyramine, and the hydroxycinnamic acid amides of serotonin and tyramine in food vegetables. Journal of Medicinal Food. 2008;11(2):385–389. doi: 10.1089/jmf.2007.514. PubMed DOI

Zhang L.-L., Tian K., Tang Z.-H., et al. Phytochemistry and pharmacology of Carthamus tinctorius L. The American Journal of Chinese Medicine. 2016;44(2):197–226. doi: 10.1142/s0192415x16500130. PubMed DOI

Kumarasamy Y., Middleton M., Reid R. G., Nahar L., Sarker S. D. Biological activity of serotonin conjugates from the seeds of Centaurea nigra . Fitoterapia. 2003;74(6):609–612. doi: 10.1016/s0367-326x(03)00144-8. PubMed DOI

Piga R., Naito Y., Kokura S., Handa O., Yoshikawa T. Inhibitory effect of serotonin derivatives on high glucose-induced adhesion and migration of monocytes on human aortic endothelial cells. British Journal of Nutrition. 2009;102(2):264–272. doi: 10.1017/S0007114508201947. PubMed DOI

Piga R., Naito Y., Kokura S., Handa O., Yoshikawa T. Protective effect of serotonin derivatives on glucose-induced damage in PC12 rat pheochromocytoma cells. British Journal of Nutrition. 2010;103(1):25–31. doi: 10.1017/S0007114509991486. PubMed DOI

Nosál' R., Pereěko T., Jančinová V., Drábiková K., Harmatha J., Sviteková K. Naturally appearing N-feruloylserotonin isomers suppress oxidative burst of human neutrophils at the protein kinase C level. Pharmacological Reports. 2011;63(3):790–798. doi: 10.1016/s1734-1140(11)70591-6. PubMed DOI

Koyama N., Kuribayashi K., Seki T., et al. Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit Low-Density Lipoprotein (LDL) oxidation and atherosclerosis in apolipoprotein E-deficient mice. Journal of Agricultural and Food Chemistry. 2006;54(14):4970–4976. doi: 10.1021/jf060254p. PubMed DOI

Koyama N., Suzuki K., Furukawa Y., et al. Effects of safflower seed extract supplementation on oxidation and cardiovascular risk markers in healthy human volunteers. British Journal of Nutrition. 2009;101(4):568–575. doi: 10.1017/S000711450803078X. PubMed DOI

Suzuki K., Tsubaki S., Fujita M., et al. Effects of safflower seed extract on arterial stiffness. Vascular Health and Risk Management. 2010;6:1007–1014. PubMed PMC

Weinblatt M. E. Rheumatoid arthritis in 2003: where are we now with treatment? Annals of the Rheumatic Diseases. 2003;62(2):94–96. doi: 10.1136/ard.62.1.94. PubMed DOI PMC

McLean-Tooke A., Aldridge C., Waugh S., Spickett G. P., Kay L. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence? Rheumatology. 2009;48(8):867–871. doi: 10.1093/rheumatology/kep101. PubMed DOI

Smolen J. S., Aletaha D. The assessment of disease activity in rheumatoid arthritis. Clinical and Experimental Rheumatology. 2010;28(3) supplement 59:S18–S27. PubMed

Bauerova K., Paulovicova E., Mihalova D., et al. Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress. Acta Biochimica Polonica. 2010;57(3):347–354. PubMed

Roy S., Sannigrahi S., Vaddepalli R. P., Ghosh B., Pusp P. A novel combination of methotrexate and epigallocatechin attenuates the overexpression of pro-inflammatory cartilage cytokines and modulates antioxidant status in adjuvant arthritic rats. Inflammation. 2012;35(4):1435–1447. doi: 10.1007/s10753-012-9457-2. PubMed DOI

Rovenský J., Stančíková M., Švík K., Utěšený J., Bauerová K., Jurčovičová J. Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli o83 (colinfant®) Folia Microbiologica. 2009;54(4):359–363. doi: 10.1007/s12223-009-0045-2. PubMed DOI

Kuncirova V., Ponist S., Mihalova D., et al. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis. Fundamental and Clinical Pharmacology. 2014;28(6):616–626. doi: 10.1111/fcp.12085. PubMed DOI

Mackovicova K., Gazova A., Kucerova D., et al. Enalapril decreases cardiac mass and fetal gene expression without affecting the expression of endothelin-1, transforming growth factor β-1, or cardiotrophin-1 in the healthy normotensive rat. Canadian Journal of Physiology and Pharmacology. 2011;89(3):197–205. doi: 10.1139/Y11-014. PubMed DOI

Harmatha J., Buděšínský M., Vokáč K., Pavlǐk M., Grüner K., Laudová V. Lignan glucosides and serotonin phenylpropanoids from the seeds of Leuzea carthamoides. Collection of Czechoslovak Chemical Communications. 2007;72(3):334–346. doi: 10.1135/cccc20070334. DOI

Pavlík M., Laudová V., Grüner K., Vokáč K., Harmatha J. High-performance liquid chromatographic analysis and separation of N-feruloylserotonin isomers. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2002;770(1-2):291–295. doi: 10.1016/S1570-0232(02)00018-1. PubMed DOI

Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 1976;72(1-2):248–254. doi: 10.1016/0003-2697(76)90527-3. PubMed DOI

Bauerova K., Acquaviva A., Ponist S., et al. Markers of inflammation and oxidative stress studied in adjuvant-induced arthritis in the rat on systemic and local level affected by pinosylvin and methotrexate and their combination. Autoimmunity. 2015;48(1):46–56. doi: 10.3109/08916934.2014.939268. PubMed DOI

Winer J., Jung C. K. S., Shackel I., Williams P. M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro . Analytical Biochemistry. 1999;270(1):41–49. doi: 10.1006/abio.1999.4085. PubMed DOI

Chtourou Y., Kamoun Z., Zarrouk W., et al. Naringenin ameliorates renal and platelet purinergic signalling alterations in high-cholesterol fed rats through the suppression of ROS and NF-κB signaling pathways. Food and Function. 2016;7(1):183–193. doi: 10.1039/c5fo00871a. PubMed DOI

Shehab N. G., Abu-Gharbieh E., Bayoumi F. A. Impact of phenolic composition on hepatoprotective and antioxidant effects of four desert medicinal plants. BMC Complementary and Alternative Medicine. 2015;15(1):401–413. doi: 10.1186/s12906-015-0919-6. PubMed DOI PMC

Roubenoff R., Roubenoff R. A., Cannon J. G., et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. The Journal of Clinical Investigation. 1994;93(6):2379–2386. doi: 10.1172/jci117244. PubMed DOI PMC

Caparroz-Assef S. M., Bersani-Amado C. A., Do Nascimento É. A., Kelmer-Bracht A. M., Ishii-Iwamoto E. L. Effects of the nonsteroidal anti-inflammatory drug nimesulide on energy metabolism in livers from adjuvant-induced arthritic rats. Research Communications in Molecular Pathology and Pharmacology. 1998;99(1):93–116. PubMed

Júnior Z. F., Ishii-Iwamoto E. L., Bersani Amado C., et al. Gluconeogenesis in the liver of arthritic rats. Cell Biochemistry and Function. 1999;17(4):271–278. doi: 10.1002/(sici)1099-0844(199912)17:4<271::aid-cbf839>3.0.co;2-p. PubMed DOI

Fedatto Z., Jr., Ishii-Iwamoto E. L., Bersani-Amado C., Maciel E. R. M., Bracht A., Kelmer-Bracht A. M. Glucose phosphorylation capacity and glycolysis in the liver of arthritic rats. Inflammation Research. 2000;49(3):128–132. doi: 10.1007/s000110050570. PubMed DOI

Kelmer-Bracht A. M., Barbosa Santos C. P., Ishii-Iwamoto E. L., Broetto-Biazon A. C., Bracht A. Kinetic properties of the glucose 6-phosphatase of the liver from arthritic rats. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease. 2003;1638(1):50–56. doi: 10.1016/s0925-4439(03)00041-3. PubMed DOI

Tsukamoto I., Kojo S. Effects of methotrexate on rat liver regeneration after partial hepatectomy. Clinical Science. 1992;82(2):181–184. doi: 10.1042/cs0820181. PubMed DOI

Iqbal M. P., Abdul Saeed S., Pertani S., Mehboobali N. Additive effect of indomethacin and methotrexate on suppression of growth in rats. Biopharmaceutics and Drug Disposition. 1999;20(8):389–395. PubMed

Ferraccioli G., Bracci-Laudiero L., Alivernini S., Gremese E., Tolusso B., de Benedetti F. Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis. Molecular Medicine. 2010;16(11-12):552–557. doi: 10.2119/molmed.2010.00067. PubMed DOI PMC

van Eden W., Wagenaar-Hilbers J. P. A., Wauben M. H. M. Current Protocols in Immunology. chapter 15, unit 15.4. 2001. Adjuvant arthritis in the rat. PubMed DOI

Baumann H., Gauldie J. The acute phase response. Immunology Today. 1994;15(2):74–80. doi: 10.1016/0167-5699(94)90137-6. PubMed DOI

Zhang D., Sun M., Samols D., Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. The Journal of Biological Chemistry. 1996;271(16):9503–9509. doi: 10.1074/jbc.271.16.9503. PubMed DOI

Kleemann R., Gervois P. P., Verschuren L., Staels B., Princen H. M. G., Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation. Blood. 2003;101(2):545–551. doi: 10.1182/blood-2002-06-1762. PubMed DOI

Lu J., Marnell L. L., Marjon K. D., Mold C., Du Clos T. W., Sun P. D. Structural recognition and functional activation of FcγR by innate pentraxins. Nature. 2008;456(7224):989–992. doi: 10.1038/nature07468. PubMed DOI PMC

Kim K.-W., Kim B.-M., Moon H.-W., Lee S.-H., Kim H.-R. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis. Arthritis Research and Therapy. 2015;17(1):41–53. doi: 10.1186/s13075-015-0563-z. PubMed DOI PMC

Gay R. E., Neidhart M., Pataky F., Tries S., Laufer S., Gay S. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis. The Journal of Rheumatology. 2001;28(9):2060–2065. PubMed

Gheorgehe K. R., Korotkova M., Catrina A. I., et al. Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids. Arthritis Research and Therapy. 2009;11(3, article R83) doi: 10.1186/ar2717. PubMed DOI PMC

Wu M.-Y., Lin T.-H., Chiu Y.-C., Liou H.-C., Yang R.-S., Fu W.-M. Involvement of 15-lipoxygenase in the inflammatory arthritis. Journal of Cellular Biochemistry. 2012;113(7):2279–2289. doi: 10.1002/jcb.24098. PubMed DOI

Ribeiro D., Freitas M., Tomé S. M., et al. Inhibition of LOX by flavonoids: a structure-activity relationship study. European Journal of Medicinal Chemistry. 2014;72:137–145. doi: 10.1016/j.ejmech.2013.11.030. PubMed DOI

Sanada H., Sekimoto M., Kamoshita A., Degawa M. Changes in expression of hepatic cytochrome P450 subfamily enzymes during development of adjuvant-induced arthritis in rats. The Journal of Toxicological Sciences. 2011;36(2):181–190. doi: 10.2131/jts.36.181. PubMed DOI

Cannon G. W., Openshaw S. J., Hibbs J. B., Jr., Hoidal J. R., Huecksteadt T. P., Griffiths M. M. Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis and Rheumatism. 1996;39(10):1677–1684. doi: 10.1002/art.1780391010. PubMed DOI

Billingham M. E. J., Gordon A. H. The role of the acute phase reaction in inflammation. Agents and Actions. 1976;6(1–3):195–200. doi: 10.1007/bf01972208. PubMed DOI

Weinberg J. B., Granger D. L., Pisetsky D. S., et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. The Journal of Experimental Medicine. 1994;179(2):651–660. doi: 10.1084/jem.179.2.651. PubMed DOI PMC

Wessels J. A. M., Huizinga T. W. J., Guchelaar H.-J. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology. 2008;47(3):249–255. doi: 10.1093/rheumatology/kem279. PubMed DOI

Kavanaugh A., St Clair E. W., McCune W. J., Braakman T., Lipsky P. Chimeric anti-tumor necrosis factor-α monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. Journal of Rheumatology. 2000;27(4):841–850. PubMed

Weisman M. H., Moreland L. W., Furst D. E., et al. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Clinical Therapeutics. 2003;25(6):1700–1721. doi: 10.1016/s0149-2918(03)80164-9. PubMed DOI

Segal R., Yaron M., Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 1990;20(3):190–200. doi: 10.1016/0049-0172(90)90060-s. PubMed DOI

Kane D., Gogarty M., O'Leary J., et al. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis & Rheumatism. 2004;50(10):3286–3295. doi: 10.1002/art.20518. PubMed DOI

Brody M., Bohm I., Bauer R. Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1β to the interleukin 1 receptor on target cells. European Journal of Clinical Chemistry and Clinical Biochemistry. 1993;31(10):667–674. PubMed

Majumdar S., Aggarwal B. B. Methotrexate suppresses NF-κB activation through inhibition of IκBα phosphorylation and degradation. The Journal of Immunology. 2001;167(5):2911–2920. doi: 10.4049/jimmunol.167.5.2911. PubMed DOI

Tak P. P., Firestein G. S. NF-κB: a key role in inflammatory diseases. The Journal of Clinical Investigation. 2001;107(1):7–11. doi: 10.1172/jci11830. PubMed DOI PMC

Makarov S. S. NF-κB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Research & Therapy. 2001;3(4):200–206. doi: 10.1186/ar300. PubMed DOI PMC

Spurlock C. F., Tossberg J. T., Matlock B. K., Olsen N. J., Aune T. M. Methotrexate inhibits NF-κB activity via long intergenic (noncoding) RNA-p21 induction. Arthritis and Rheumatology. 2014;66(11):2947–2957. doi: 10.1002/art.38805. PubMed DOI PMC

Spurlock C. F., III, Gass H. M., Bryant C. J., Wells B. C., Olsen N. J., Aune T. M. Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes. Rheumatology. 2014;54(1):178–187. doi: 10.1093/rheumatology/keu279.keu279 PubMed DOI PMC

Häupl T., Yahyawi M., Lübke C., et al. Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. Journal of Biomolecular Screening. 2007;12(3):328–340. doi: 10.1177/1087057107299261. PubMed DOI

Lee C., Lim H.-K., Sakong J., Lee Y.-S., Kim J.-R., Baek S.-H. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1β and IL-6 production. Molecular Pharmacology. 2006;69(3):1041–1047. PubMed

Samavati L., Rastogi R., Du W., Hüttemann M., Fite A., Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Molecular Immunology. 2009;46(8-9):1867–1877. doi: 10.1016/j.molimm.2009.02.018. PubMed DOI

Ma C., Wang Y., Dong L., Li M., Cai W. Anti-inflammatory effect of resveratrol through the suppression of NF-κB and JAK/STAT signaling pathways. Acta Biochimica et Biophysica Sinica. 2015;47(3):207–213. doi: 10.1093/abbs/gmu135. PubMed DOI

Miklossy G., Hilliard T. S., Turkson J. Therapeutic modulators of STAT signalling for human diseases. Nature Reviews Drug Discovery. 2013;12(8):611–629. doi: 10.1038/nrd4088. PubMed DOI PMC

Roubenoff R., Freeman L. M., Smith D. E., Abad L. W., Dinarello C. A., Kehayias J. J. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis & Rheumatism. 1997;40(3):534–539. doi: 10.1002/art.1780400320. PubMed DOI

Walsmith J., Roubenoff R. Cachexia in rheumatoid arthritis. International Journal of Cardiology. 2002;85(1):89–99. doi: 10.1016/S0167-5273(02)00237-1. PubMed DOI

Takimoto T., Suzuki K., Arisaka H., Murata T., Ozaki H., Koyama N. Effect of N-(p-coumaroyl)serotonin and N-feruloylserotonin, major anti-atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of vascular smooth muscle cells. Molecular Nutrition and Food Research. 2011;55(10):1561–1571. doi: 10.1002/mnfr.201000545. PubMed DOI

Schatzberg A. F., Nemeroff Ch. B. The American Psychiatric Publishing Textbook of Psychopharmacology. American Psychiatric Publishing; 2009. DOI

Arreola R., Becerril-Villanueva E., Cruz-Fuentes C., et al. Immunomodulatory effects mediated by serotonin. Journal of Immunology Research. 2015;2015:21. doi: 10.1155/2015/354957.354957 PubMed DOI PMC

Sufka K. J., Schomburg F. M., Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacology, Biochemistry and Behavior. 1992;41(1):53–56. doi: 10.1016/0091-3057(92)90058-N. PubMed DOI

Pertsch M., Krause K., Hirschelmann R. A comparison of serotonin (5-HT) blood levels and activity of 5-HT2 antagonists in adjuvant arthritic Lewis and Wistar rats. Agents and Actions. 1993;38(supplement 2):C98–C101. doi: 10.1007/bf01991150. PubMed DOI

Harbuz M. S., Perveen-Gill Z., Lalies M. D., Jessop D. S., Lightman S. L., Chowdrey H. S. The role of endogenous serotonin in adjuvant-induced arthritis in the rat. British Journal of Rheumatology. 1996;35(2):112–116. doi: 10.1093/rheumatology/35.2.112. PubMed DOI

Chabbi-Achengli Y., Coman T., Collet C., et al. Serotonin is involved in autoimmune arthritis through Th17 immunity and bone resorption. The American Journal of Pathology. 2016;186(4):927–937. doi: 10.1016/j.ajpath.2015.11.018. PubMed DOI

Seidel M. F., Fiebich B. L., Ulrich-Merzenich G., Candelario-Jalil E., Koch F.-W., Vetter H. Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells. Rheumatology International. 2008;28(10):1017–1022. doi: 10.1007/s00296-008-0564-1. PubMed DOI

Paskova L., Kuncirova V., Nosal R., Siskova K., Paulikova I., Bauerova K. The effect of N-feruloylserotonin on RNA expression of iNOS and of key proinflammatory cytokines Il-1β and TNFα in rat adjuvant arthritis. Zbornik prednasok a posterov, XXIV, Biochemicky zjazd SSBMB A ČSBMB, p. 209, 2014.

Hochberg M. C., Silman A. J., Smolen J. S., Weinblatt M. E., Weisman M. H. Rheumatology. London, UK: Elsevier Health Sciences; 2014.

Niu X., He D., Deng S., et al. Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis. Molecular Immunology. 2011;49(1-2):290–296. doi: 10.1016/j.molimm.2011.08.020. PubMed DOI